Table 1 Baseline characteristics
Variable | LRC (n = 125) | RRC (n = 100) | P* |
|---|---|---|---|
Age (years) | 63.62 ± 12.43 | 67.13 ± 13.11 | 0.041 |
Male | 55 (44.00%) | 53 (53.00%) | 0.179 |
Body mass index (kg/m2) | 23.07 ± 4.85 | 22.64 ± 3.96 | 0.478 |
Preoperative CEA (ng/ml) | 11.16 ± 45.64 | 12.34 ± 23.68 | 0.815 |
Tumor site | 0.958 | ||
Ileocecal part | 18 (14.40%) | 28 (28.00%) | |
Ascending colon | 43 (34.40%) | 27 (43.00%) | |
Hepatic flexure | 64 (51.20%) | 45 (27.00%) | |
ASA grade (No, %) | 0.696 | ||
I-II | 53 (42.40%) | 45 (45.00%) | |
III-IV | 72 (57.60%) | 55 (55.00%) | |
Tumor pathological stage | > 0.999 | ||
I | 24 (19.20%) | 16 (16.00%) | |
II | 62 (49.60%) | 51 (51.00%) | |
III | 39 (31.20%) | 33 (33.00%) | |
Pathological differentiation degree | 0.062 | ||
Low | 33 (10.40%) | 38 (38.00%) | |
Moderate and high | 92 (73.60%) | 62 (62.00%) |